Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 74

Sort by

Sort Order Select

Journal Articles

Disease Progression, Hospital Readmissions, and Clinical Outcomes of Patients with Steroid-Refractory Acute Graft-Versus-Host Disease: A Multicenter Chart Review

Jingbo Yu, PhD, Becky Hanna, Dilan Paranagama, PhD, Jackson Tang, Ahmad Naim, MD, John P Galvin, MDMS,MPH

Blood (2019) 134 (Supplement_1): 1994.

https://doi.org/10.1182/blood-2019-127492

Published: 2019

Journal Articles

Analysis of Deficiency of Adenosine Deaminase 2 Pathogenesis Based on Single Cell RNA Sequencing of Monocytes

Naoki Watanabe, Shouguo Gao, PhD, Sachiko Kajigaya, Carrie Diamond, MD, Lemlem Alemu, BS, Amanda Ombrello, MD, Neal S. Young, MD

Blood (2019) 134 (Supplement_1): 2317.

https://doi.org/10.1182/blood-2019-123859

Published: 2019

Journal Articles

Time to Change Our Practice: Experience in the Treatment of Steroid Refractory Graft Versus Host Disease in a Universitary Hospital in Chile

Nicolas Triantafilo, MD, Mauricio Sarmiento Maldonado, MD, Felipe Palacios, MD, James Campbell, MD, Vicente Sandoval, MD, Andres Rojas, MD, Jara Veronica, Soto Katherine, Silvana Arellano, Carla Lorca, Isabel Pizarro, Elizabeth Rivera, Mauricio Galleguillos, Isabel Rodriguez, Pablo Bertin, MD, Mauricio Ocqueteau, MD, Jaime Pereira, MD

Blood (2019) 134 (Supplement_1): 5683.

https://doi.org/10.1182/blood-2019-131737

Published: 2019

Journal Articles

Outcome and Risk Factors of Transplantation-Associated Active Tuberculosis in Allogeneic Haematopoietic Stem Cell Transplantation: A Nested Case Control Study

Yanmin Zhao, MD, Apeng Yang, MD, Jimin Shi, MD, Yi Luo, MD, Xiaoyu Lai, PhD, Yamin Tan, MD, Jian Yu, MD, He Huang, MD PhD

Blood (2018) 132 (Supplement 1): 3427.

https://doi.org/10.1182/blood-2018-99-119027

Published: 2018

Journal Articles

Ruxolitinib Combined with Etanercept for Patients with Corticosteroid-Refractory Acute Graft Versus Host Disease after Allogeneic Stem Cell Transplantation: A Multi-Center Prospective Study

Yanmin Zhao, MD, Jimin Shi, MD, Xiaoqing Li, Yi Luo, MD, Yamin Tan, MD, Xiaoyu Lai, PhD, Jian Yu, MD, Jianping Lan, PhD, Wanmao Ni, PhD, Lieguang Chen, MD, He Huang, MD PhD

Blood (2018) 132 (Supplement 1): 4561.

https://doi.org/10.1182/blood-2018-99-118649

Published: 2018

Journal Articles

Deficiency of Adenosine Deaminase 2 (DADA2) Presenting As Familial Hodgkin Lymphoma

Fahad Alabbas, Omar Alsharief, Isabelle Meyts, Fatma Albatniji, Michael Hershfield, Adnan Mansoor, MD PhD, Ghaleb Elyamany, MD PhD

Blood (2018) 132 (Supplement 1): 5373.

https://doi.org/10.1182/blood-2018-99-116431

Published: 2018

Journal Articles

Evaluating Anti-TNF-Alpha Therapy in Patients with Relapsed and Refractory Langerhans Cell Histiocytosis

Thomas Burke, BS, Alejandra Legarreta, MD, Howard Lin, Brooks Scull, Olive S. Eckstein, MD, Kenneth L. McClain, MD PhD, Carl E. Allen, MD PhD

Blood (2018) 132 (Supplement 1): 4941.

https://doi.org/10.1182/blood-2018-99-114295

Published: 2018

Journal Articles

Histopathologic Acute Lung Injury after Allogeneic Hematopoietic Cell Transplantation: Clinical Findings, Radiologic Features, Treatments and Outcomes

Mehrdad Hefazi, MD, Shahrukh K. Hashmi, MD MPH, Anja C. Roden, MD, Mrinal M. Patnaik, MD MBBS, Reona Sakemura, MD PhD, Nandita Khera, MD, Vivek Roy, MD, Cassie C. Kennedy, MD, William J. Hogan, MB, BCh, Mark R. Litzow, MD, Hemang Yadav, MBBS

Blood (2018) 132 (Supplement 1): 2113.

https://doi.org/10.1182/blood-2018-99-118930

Published: 2018

Journal Articles

A Phase I/II Study on the Anti-CD3/CD7 Immunotoxin Combination (T-GuardTM) for the Treatment of Steroid-Refractory Acute Gvhd

Christoph Groth, MD, Lenneke F J Groningen, Manita E J Bremmers, Frank W M B Preijers, Harry Dolstra, Tiago R Matos, Christian Reicherts, Eric G van Hooren, Ypke V J M van Oosterhout, John E Levine, MD, James L Ferrara, Nicole M A Blijlevens, Matthias Stelljes, MD, Walter J F M van der Velden

Blood (2017) 130 (Supplement 1): 513.

https://doi.org/10.1182/blood.V130.Suppl_1.513.513

Published: 2017

Journal Articles

Treatment of Patients with Steroid Refractory Acute Graft Vs Host Disease (SR-GvHD): A Matched Paired Analysis of Anti-CD26 (Begelomab) Compared to Other Treatment

Andrea Bacigalupo, MD, H. Joachim Deeg, MD, Dolores Caballero, MD PhD, Francesca Gualandi, MD, Anna Maria Raiola, MD, Riccardo Varaldo, MD, Carmen Di Grazia, MD, Lucia López Corral, PhD MD, Maria Teresa van Lint, MD

Blood (2016) 128 (22): 671.

https://doi.org/10.1182/blood.V128.22.671.671

Published: 2016

Journal Articles

Cerebral Toxoplasmosis in a Patient with Prolonged CD4 Lymphopenia Post Autologous Haematopoietic Stem Cell Transplant

Arielle van Mourik, MBBS BBiomedSci, Andrew P Grigg, MBBS MD

Blood (2016) 128 (22): 4902.

https://doi.org/10.1182/blood.V128.22.4902.4902

Published: 2016

Journal Articles

Expandation of CD56-Bright NK Cell in Patients with Steroid-Refractory Graft-Versus-Host Disease Treated with Basiliximab and Etanercept

Lixia Sheng, MD, He Huang, MD PhD, Yamin Tan, Yi Luo, Yongxian Hu, Huarui Fu, Jimin Shi

Blood (2016) 128 (22): 5793.

https://doi.org/10.1182/blood.V128.22.5793.5793

Published: 2016

Journal Articles

Successful Treatment of Animal Models of Acute Graft-Versus-Host Disease with Small-Molecule TNF Inhibitor

Haiyan Gong, Yigeng Cao, Peng Liu, Haiyan Zhu, Zhezhe Wang, Fei Xiang, Tong Wang, Sizhou Feng, Mingzhe Han, Hongbo R. Luo, Jiaxi Zhou, Yuanfu Xu

Blood (2016) 128 (22): 4714.

https://doi.org/10.1182/blood.V128.22.4714.4714

Published: 2016

Journal Articles

Tumor Necrosis Factor-Alpha Inhibitor Medications for Inflammatory Conditions and Incidence of Multiple Myeloma

Gregory S. Calip, PharmD, MPH, PhD, Wan-Ju Lee, MS, Todd A. Lee, PharmD, PhD, Glen T. Schumock, PharmD, MBA, PhD, Brian C.-H. Chiu, PhD

Blood (2015) 126 (23): 2954.

https://doi.org/10.1182/blood.V126.23.2954.2954

Published: 2015

Journal Articles

Excellent Therapeutic Results Achieved in Salvage Therapy for Steroid-Refractory Grades III-IV Acute Gvhd with Basiliximab and Etanercept: A Multicenter Prospective Study

Yamin Tan, Haowen Xiao, Jianping Lan, Yi Luo, Jimin Shi, Jingsong He, PhD, Xiaoyu Lai, Weiyan Zheng, Zhen Cai, He Huang, MD PhD

Blood (2015) 126 (23): 3130.

https://doi.org/10.1182/blood.V126.23.3130.3130

Published: 2015

Journal Articles

Rescue of a Terminally Ill Patient with Chemo-Refractory Acute Lymphoblastic Leukemia Carrying Bcr/Abl and TP53 Mutations Based on a 4th Generation CD19 Chimeric Antigen Receptor-Engineered T (CAR-T) Therapy

Ting Niu, MD PhD, Lung-Ji Chang, PhD, Jinrong Yang, MD, Yuchen Liu, MSc, Lujia Dong, MD, Wei Wang, PhD, Ting Liu, MD

Blood (2015) 126 (23): 5431.

https://doi.org/10.1182/blood.V126.23.5431.5431

Published: 2015

Journal Articles

Extracorporeal Photopheresis As Second Line Therapy for Steroid Refractory Acute Gvhd: Retrospective Study of Long-Term Outcomes

Rohini Radia, MBChB, Emma Das-Gupta, MD, Guillermo Orti, MD, Donal McLornan, MDPhD, Majid A. Kazmi, Christopher P Fox, PhD, Jenny L. Byrne, PhD, Nigel H. Russell, MD, Kavita Raj, MDPhD

Blood (2015) 126 (23): 1944.

https://doi.org/10.1182/blood.V126.23.1944.1944

Published: 2015

Journal Articles

Risk of Non-Hodgkin Lymphoma Following Treatment of Inflammatory Conditions with Tumor Necrosis Factor-Alpha Inhibitors

Gregory S. Calip, PharmD, MPH, PhD, Wan-Ju Lee, MS, Todd A. Lee, PharmD, PhD, Glen T. Schumock, PharmD, MBA, PhD, Brian C.-H. Chiu, PhD

Blood (2015) 126 (23): 2653.

https://doi.org/10.1182/blood.V126.23.2653.2653

Published: 2015

Journal Articles

Chimeric Antigen Receptor 4SCAR19-Modified T Cells in Acute Lymphoid Leukemia: a Phase II Multi-Center Clinical Trial in China

Lujia Dong, MD, Lung-Ji Chang, PhD, Zhiyong Gao, MD, Dao-Pei Lu, MD, Jian-Ping Zhang, MD, Jing-Bo Wang, MD, Le-Ping Zhang, MD, Yu-Hong Chen, MD, Hu-Yong Zheng, MD, Ting Liu, Ting Niu, MD PhD, He Huang, MD PhD, Rong Liu, MD, Heng-Xiang Wang, MD, Li Gao, MD, Tong-Hua Yang, MD, Xun Lai, MD

Blood (2015) 126 (23): 3774.

https://doi.org/10.1182/blood.V126.23.3774.3774

Published: 2015

Journal Articles

TNF-mediated inflammation represses GATA1 and activates p38 MAP kinase in RPS19-deficient hematopoietic progenitors

Elena Bibikova, Min-Young Youn, Nadia Danilova, Yukako Ono-Uruga, Yoan Konto-Ghiorghi, Rachel Ochoa, Anupama Narla, Bertil Glader, Shuo Lin, Kathleen M. Sakamoto

Blood (2014) 124 (25): 3791–3798.

https://doi.org/10.1182/blood-2014-06-584656

Published: 2014

Includes: Supplemental data

NARROW

Disease Progression, Hospital Readmissions, and Clinical Outcomes of Patients with Steroid-Refractory Acute Graft-Versus-Host Disease: A Multicenter Chart Review

Analysis of Deficiency of Adenosine Deaminase 2 Pathogenesis Based on Single Cell RNA Sequencing of Monocytes

Time to Change Our Practice: Experience in the Treatment of Steroid Refractory Graft Versus Host Disease in a Universitary Hospital in Chile

Outcome and Risk Factors of Transplantation-Associated Active Tuberculosis in Allogeneic Haematopoietic Stem Cell Transplantation: A Nested Case Control Study

Ruxolitinib Combined with Etanercept for Patients with Corticosteroid-Refractory Acute Graft Versus Host Disease after Allogeneic Stem Cell Transplantation: A Multi-Center Prospective Study

Deficiency of Adenosine Deaminase 2 (DADA2) Presenting As Familial Hodgkin Lymphoma

Evaluating Anti-TNF-Alpha Therapy in Patients with Relapsed and Refractory Langerhans Cell Histiocytosis

Histopathologic Acute Lung Injury after Allogeneic Hematopoietic Cell Transplantation: Clinical Findings, Radiologic Features, Treatments and Outcomes

A Phase I/II Study on the Anti-CD3/CD7 Immunotoxin Combination (T-GuardTM) for the Treatment of Steroid-Refractory Acute Gvhd

Treatment of Patients with Steroid Refractory Acute Graft Vs Host Disease (SR-GvHD): A Matched Paired Analysis of Anti-CD26 (Begelomab) Compared to Other Treatment

Cerebral Toxoplasmosis in a Patient with Prolonged CD4 Lymphopenia Post Autologous Haematopoietic Stem Cell Transplant

Expandation of CD56-Bright NK Cell in Patients with Steroid-Refractory Graft-Versus-Host Disease Treated with Basiliximab and Etanercept

Successful Treatment of Animal Models of Acute Graft-Versus-Host Disease with Small-Molecule TNF Inhibitor

Tumor Necrosis Factor-Alpha Inhibitor Medications for Inflammatory Conditions and Incidence of Multiple Myeloma

Excellent Therapeutic Results Achieved in Salvage Therapy for Steroid-Refractory Grades III-IV Acute Gvhd with Basiliximab and Etanercept: A Multicenter Prospective Study

Rescue of a Terminally Ill Patient with Chemo-Refractory Acute Lymphoblastic Leukemia Carrying Bcr/Abl and TP53 Mutations Based on a 4th Generation CD19 Chimeric Antigen Receptor-Engineered T (CAR-T) Therapy

Extracorporeal Photopheresis As Second Line Therapy for Steroid Refractory Acute Gvhd: Retrospective Study of Long-Term Outcomes

Risk of Non-Hodgkin Lymphoma Following Treatment of Inflammatory Conditions with Tumor Necrosis Factor-Alpha Inhibitors

Chimeric Antigen Receptor 4SCAR19-Modified T Cells in Acute Lymphoid Leukemia: a Phase II Multi-Center Clinical Trial in China

TNF-mediated inflammation represses GATA1 and activates p38 MAP kinase in RPS19-deficient hematopoietic progenitors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only